Your browser doesn't support javascript.
loading
Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?
Vanhaecke, Amber; Cutolo, Maurizio; Distler, Oliver; Riccieri, Valeria; Allanore, Yannick; Denton, Christopher P; Hachulla, Eric; Ingegnoli, Francesca; Deschepper, Ellen; Avouac, Jérôme; Jordan, Suzana; Launay, David; Melsens, Karin; Pizzorni, Carmen; Sulli, Alberto; Vasile, Massimiliano; Herrick, Ariane L; Smith, Vanessa.
Affiliation
  • Vanhaecke A; Department of Internal Medicine, Ghent University.
  • Cutolo M; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
  • Distler O; Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCCS San Martino Polyclinic Hospital, Genoa, Italy.
  • Riccieri V; Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Allanore Y; Department of Internal Medicine and Medical Specialties, Sapienza University of Rome, Rome, Italy.
  • Denton CP; Service de Rheumatology, Université de Paris, Hôpital Cochin, AP-HP CUP, Paris, France.
  • Hachulla E; Department of Rheumatology, University College London, Royal Free Hospital, London, UK.
  • Ingegnoli F; Institute for Translational Research in Inflammation (INFINITE), Université de Lille.
  • Deschepper E; INSERM.
  • Avouac J; Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Autoimmunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), CHU Lille, Lille, France.
  • Jordan S; Division of Clinical Rheumatology, ASST Pini-CTO.
  • Launay D; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milano, Italy.
  • Melsens K; Biostatistics Unit, Department of Public Health and Primary Care, Ghent University, Ghent, Belgium.
  • Pizzorni C; Service de Rheumatology, Université de Paris, Hôpital Cochin, AP-HP CUP, Paris, France.
  • Sulli A; Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Vasile M; Institute for Translational Research in Inflammation (INFINITE), Université de Lille.
  • Herrick AL; INSERM.
  • Smith V; Service de Médecine Interne et Immunologie Clinique, Centre de Référence des Maladies Autoimmunes Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), CHU Lille, Lille, France.
Rheumatology (Oxford) ; 61(11): 4384-4396, 2022 11 02.
Article in En | MEDLINE | ID: mdl-35176132
ABSTRACT

OBJECTIVES:

Nailfold videocapillaroscopy (NVC) plays a well-established role in differentiating primary from secondary RP due to SSc. However, the association of NVC with novel severe organ involvement/progression in SSc has never been evaluated in a multicentre, multinational study, which we now perform for the first time.

METHODS:

Follow-up data from 334 SSc patients [265 women; 18 limited SSc (lSSc)/203 lcSSc/113 dcSSc] registered between November 2008 and January 2016 by seven tertiary centres in the EUSTAR-database, were analysed. Novel severe organ involvement/progression was defined as new/progressive involvement of the peripheral vasculature, lungs, heart, skin, gastrointestinal tract, kidneys, musculoskeletal system, or death, at the 12- or 24-month follow-up. NVC images at enrolment were quantitatively and qualitatively evaluated according to the standardized definitions of the EULAR Study Group on Microcirculation in Rheumatic Diseases. Uni- and multivariable logistic regression modelling (ULR, MLR) was performed.

RESULTS:

Of the 334 included SSc patients, 257 (76.9%) developed novel overall severe organ involvement/progression. Following MLR, normal capillary density was associated with less-frequent novel overall severe organ involvement/progression [odds ratio (OR) = 0.77, P < 0.001] and novel peripheral vascular involvement (OR = 0.79, P = 0.043); microhaemorrhages were associated with less novel pulmonary hypertension (OR = 0.47, P = 0.029); and a 'severe' (active/late) NVC pattern was associated with novel overall severe organ involvement/progression (OR = 2.14, P = 0.002) and skin progression (OR = 1.70, P = 0.049).

CONCLUSIONS:

Our results suggest that NVC may be a promising biomarker in SSc, certainly warranting further investigation. Despite the participation of tertiary centres, which follow their patients in a standardized way, we were underpowered to detect associations with infrequent severe organ involvement/progression.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Scleroderma, Systemic / Scleroderma, Diffuse Limits: Female / Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Scleroderma, Systemic / Scleroderma, Diffuse Limits: Female / Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2022 Type: Article